Evidence map›Paper›PMID 40921061›Full record

ArticleJMIR human factors2025

Need Analysis of Clinician-Oriented Integrated Precision Oncology Decision Support Tools: Qualitative Descriptive Study.

Sheng Zheng, Yi Feng, Jieran Long, Xiang Li, Meng Zhang, Hui Chen, Xue Du, Huilong Duan, Shuqin Jia, Nan Wu and 1 more

Abstract read
In one paragraph

Article in JMIR human factors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sheng Zheng *College of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, China.ORCID 0009-0005-1570-8495
Yi Feng *Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Center for Molecular Diagnosis, Peking University Cancer Hospital & Institute, Beijing, China.ORCID 0000-0002-2445-1290
Jieran LongDepartment of Thoracic Oncology, Peking University Cancer Hospital & Institute, Beijing, China.ORCID 0000-0001-9979-6915
Xiang LiKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Thoracic Surgery II, Peking University Cancer Hospital & Institute, Beijing, China.ORCID 0000-0003-2817-7433
Meng ZhangKey laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Center for Molecular Diagnosis, Peking University Cancer Hospital & Institute, Beijing, China.ORCID 0000-0003-1653-9230
Hui ChenCollege of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, China.ORCID 0009-0009-4189-944X
Xue DuKey laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Center for Molecular Diagnosis, Peking University Cancer Hospital & Institute, Beijing, China.ORCID 0000-0001-9424-0520
Huilong DuanCollege of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, China.ORCID 0000-0003-3893-213X
Shuqin JiaState Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research Center for Molecular Diagnosis, Peking University Cancer Hospital & Institute Beijing, Beijing, China.ORCID 0000-0001-8092-1739
Nan WuState Key Laboratory of Molecular Oncology, Beijing Key Laboratory of Carcinogenesis and Translational Research, Department of Thoracic Surgery II, Peking University Cancer Hospital & Institute, Beijing, China.ORCID 0000-0002-3531-1656
Xudong LuCollege of Biomedical Engineering & Instrument Science, Zhejiang University, Hangzhou, China.ORCID 0000-0001-7658-5250

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe rapid advancement of next-generation sequencing has significantly expanded the landscape of precision medicine. However, health care professionals face increasing challenges in keeping pace with the growing body of oncological knowledge and integrating it effectively into clinical workflows. Precision oncology decision support (PODS) tools aim to assist clinicians in navigating this complexity, yet their current functionalities only partially address clinical needs. A lack of comprehensive needs assessment may result in unaddressed requirements, limiting the effectiveness of these tools in real-world practice.

objectiveThis study aimed to explore clinicians' needs and expectations regarding the functionalities of integrated PODS tools, providing insights into essential features that could enhance their usability and impact.

methodsWe conducted a qualitative investigation at Peking University Cancer Hospital to explore clinicians' needs and expectations for the functions of integrated PODS tools. Data were collected through 143 structured participant observations during multidisciplinary team meetings and 17 in-depth semistructured interviews with a diverse group of oncology specialists, including physicians, surgeons, molecular biologists, radiotherapists, radiologists, and pathologists. Thematic analysis was applied to identify key functional requirements, and a requirements framework was formed.

resultsThree overarching functional needs emerged: (1) better access to oncological knowledge, including support for therapy selection (guidelines, conferences, and consensuses), clinical trials, drug and treatment information, and complex case knowledge, as well as improved diagnostic and prognostic insights; (2) clinical contextualization and resource navigation, referring to the process of contextualizing scientific knowledge within real-world clinical settings, including access to clinical trials and drugs, along with predictive models for treatment response; and (3) support abilities in the decision-making process, highlighting the need for integration of flexible biological knowledge and phenotypic data; automated patient information synthesis; improved data visualization; and optimized retrieval, recommendation, and question-answering functionalities. A functional framework for integrated PODS tools was proposed based on these findings.

conclusionsThe study conducted a qualitative descriptive observation and interview in the use, needs of integrated PODS tools. PODS tools serve as complex, multilevel decision support systems. A clear understanding of clinicians' actual needs is crucial for their refinement and practical adoption. By capturing perspectives directly from oncology professionals, this study provides actionable insights into the functional enhancements required for PODS tools, ultimately aiming to bridge the gap between genomic advancements and clinical decision-making in precision oncology.

Indexed as

Decision Support Systems, ClinicalMedical OncologyNeeds AssessmentPrecision MedicineFemaleHumansMaleQualitative Researchartificial intelligencefunctional frameworkneeds analysisprecision oncology decision supportsemistructured in-depth interviewstructured observation

Identifiers

PMID40921061
PMCPMC12455164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.